Lack of Significant Metabolic Abnormalities in Mice with Liver-Specific Disruption of 11β-Hydroxysteroid Dehydrogenase Type 1

Glucocorticoids (GC) are implicated in the development of metabolic syndrome, and patients with GC excess share many clinical features, such as central obesity and glucose intolerance. In patients with obesity or type 2 diabetes, systemic GC concentrations seem to be invariably normal. Tissue GC con...

詳細記述

保存先:
書誌詳細
主要な著者: Lavery, Gareth G., Zielinska, Agnieszka E., Gathercole, Laura L., Hughes, Beverly, Semjonous, Nina, Guest, Phillip, Saqib, Khalid, Sherlock, Mark, Reynolds, Gary, Morgan, Stuart A., Tomlinson, Jeremy W., Walker, Elizabeth A., Rabbitt, Elizabeth H., Stewart, Paul M.
フォーマット: Artigo
言語:Inglês
出版事項: Endocrine Society 2012
主題:
Glucocorticoids-CRH-ACTH-Adrenal
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3475725/
https://ncbi.nlm.nih.gov/pubmed/22555437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2012-1019
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料